RK

Rajesh Kelji Balwant

Director Director DIN 06651636
DIN 06651636 First appointment Aug 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2013
Shareholding value •••• Premium profile

About Rajesh Kelji Balwant

Data last updated:

Rajesh Kelji Balwant was a Director at Big Labs Private Limited (2013–2014) and Director at Big Pharmatech Private Limited (2013–2015). The companies operate in Trading and Business Services.

DIN 06651636
Primary Designation Director
Industry Trading
First Appointment 27 Aug 2013

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Big Labs Private Limited U24233MH2012PTC229077
Director27 Aug 20132012₹1.24 Cr (FY 2017)Active
Big Pharmatech Private Limited U74900PN2013PTC149679
Director04 Dec 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Big Labs Private Limited
Big Pharmatech Private Limited
Premium access

Shareholding and investment profile for Rajesh Kelji Balwant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kelji Balwant

Rajesh Kelji Balwant was first appointed on 27 Aug 2013 as Director at Big Labs Private Limited.

Rajesh Kelji Balwant held 2 earlier board appointments: Big Labs Private Limited (Director, 27 Aug 2013 to 01 Mar 2014); Big Pharmatech Private Limited (Director, 04 Dec 2013 to 01 Jan 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available